Report Detail
Global Biogeneric Drugs Market Research Report 2019
- RnM3122517 |
- 14 March, 2019 |
- Global |
- 109 Pages |
- QYResearch |
- Pharma & Healthcare
Biogenerics drugs are the biological products manufactured after end of patent of innovator biopharmaceuticals. Biogenerics also known as biosimilars in Europe, follows-on-biologics in US and subsequent entry biological in japan. Due to their high degree of similarity with the biological reference product, they have no clinically evidenced and meaningful differences from the reference product in terms of quality, safety or efficacy. Biogenerics drugs provide effective treatment for number of serious and life-threatening illness because of their high specificity and activity. Biogeneric are more complex compared to small molecule drugs. Their quality and safety are highly dependent on the process of production (choice of cell type, development of the genetically modified cell for production, etc.), purification and formulation. The constitution of the biogeneric drugs can be either small molecules such as human insulin or erythropoietin, or complex molecules such as monoclonal antibodies. Biogeneric drugs are increasing gaining prominence given the loss of exclusivity of big branded drugs. In Europe, biogenerics can be marketed through independent applicant following expiry of patent and market exclusivity periods of the reference product. Regulatory harmonization, naming and labelling, innovative licensure norms and route to market for the biogeneric drugs are issues expected to gain attention and traction from big drug makers in the forthcoming years.
Biogeneric drugs market is expected to increase in forecast period due to increased treatment options, value added services to care patient and healthcare community. Due to drugs introduces competition, increasing affordability of biologics which delivers saving for healthcare systems are the same factors which increase biogeneric drugs market. Introduction of affordable, high-quality biogenerics drugs improves access to life changing medicine for patients worldwide. Opportunities for generic drug products is huge but there are regulations that must be adhered to when strategizing the best ways to maximize a company’s return. Government regulation may be adhere the growth of drug development investment or planning an entry into a market with a new biogeneric products.
The global Biogeneric Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Biogeneric Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biogeneric Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Sandoz International
Teva pharmaceutical industries
Mylan
3SBio
Shanghai Fosun Pharmaceutical
Tonghua Dongbao Pharmaceutical
Biocon
Reliance life sciences
Probiomed
Biosidus
AMEGA Biotech
Celltrion
LG life Science
Dong-A Pharmaceutical
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Insulins
Growth Hormones
Monoclonal Antibodies
Others
Segment by Application
Hospital
Clinics
Research Centers
Table of Contents
Executive Summary
1 Biogeneric Drugs Market Overview
- 1.1 Product Overview and Scope of Biogeneric Drugs
- 1.2 Biogeneric Drugs Segment by Type
- 1.2.1 Global Biogeneric Drugs Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Insulins
- 1.2.3 Growth Hormones
- 1.2.4 Monoclonal Antibodies
- 1.2.5 Others
- 1.3 Biogeneric Drugs Segment by Application
- 1.3.1 Biogeneric Drugs Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Clinics
- 1.3.4 Research Centers
- 1.4 Global Biogeneric Drugs Market by Region
- 1.4.1 Global Biogeneric Drugs Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Biogeneric Drugs Market Size
- 1.5.1 Global Biogeneric Drugs Revenue (2014-2025)
- 1.5.2 Global Biogeneric Drugs Production (2014-2025)
2 Global Biogeneric Drugs Market Competition by Manufacturers
- 2.1 Global Biogeneric Drugs Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Biogeneric Drugs Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Biogeneric Drugs Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Biogeneric Drugs Production Sites, Area Served, Product Types
- 2.5 Biogeneric Drugs Market Competitive Situation and Trends
- 2.5.1 Biogeneric Drugs Market Concentration Rate
- 2.5.2 Biogeneric Drugs Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Biogeneric Drugs Production Market Share by Regions
- 3.1 Global Biogeneric Drugs Production Market Share by Regions
- 3.2 Global Biogeneric Drugs Revenue Market Share by Regions (2014-2019)
- 3.3 Global Biogeneric Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Biogeneric Drugs Production
- 3.4.1 North America Biogeneric Drugs Production Growth Rate (2014-2019)
- 3.4.2 North America Biogeneric Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Biogeneric Drugs Production
- 3.5.1 Europe Biogeneric Drugs Production Growth Rate (2014-2019)
- 3.5.2 Europe Biogeneric Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Biogeneric Drugs Production (2014-2019)
- 3.6.1 China Biogeneric Drugs Production Growth Rate (2014-2019)
- 3.6.2 China Biogeneric Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Biogeneric Drugs Production (2014-2019)
- 3.7.1 Japan Biogeneric Drugs Production Growth Rate (2014-2019)
- 3.7.2 Japan Biogeneric Drugs Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Biogeneric Drugs Consumption by Regions
- 4.1 Global Biogeneric Drugs Consumption by Regions
- 4.2 North America Biogeneric Drugs Consumption (2014-2019)
- 4.3 Europe Biogeneric Drugs Consumption (2014-2019)
- 4.4 China Biogeneric Drugs Consumption (2014-2019)
- 4.5 Japan Biogeneric Drugs Consumption (2014-2019)
5 Global Biogeneric Drugs Production, Revenue, Price Trend by Type
- 5.1 Global Biogeneric Drugs Production Market Share by Type (2014-2019)
- 5.2 Global Biogeneric Drugs Revenue Market Share by Type (2014-2019)
- 5.3 Global Biogeneric Drugs Price by Type (2014-2019)
- 5.4 Global Biogeneric Drugs Production Growth by Type (2014-2019)
6 Global Biogeneric Drugs Market Analysis by Applications
- 6.1 Global Biogeneric Drugs Consumption Market Share by Application (2014-2019)
- 6.2 Global Biogeneric Drugs Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Biogeneric Drugs Business
- 7.1 Sandoz International
- 7.1.1 Sandoz International Biogeneric Drugs Production Sites and Area Served
- 7.1.2 Biogeneric Drugs Product Introduction, Application and Specification
- 7.1.3 Sandoz International Biogeneric Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Teva pharmaceutical industries
- 7.2.1 Teva pharmaceutical industries Biogeneric Drugs Production Sites and Area Served
- 7.2.2 Biogeneric Drugs Product Introduction, Application and Specification
- 7.2.3 Teva pharmaceutical industries Biogeneric Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Mylan
- 7.3.1 Mylan Biogeneric Drugs Production Sites and Area Served
- 7.3.2 Biogeneric Drugs Product Introduction, Application and Specification
- 7.3.3 Mylan Biogeneric Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 3SBio
- 7.4.1 3SBio Biogeneric Drugs Production Sites and Area Served
- 7.4.2 Biogeneric Drugs Product Introduction, Application and Specification
- 7.4.3 3SBio Biogeneric Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Shanghai Fosun Pharmaceutical
- 7.5.1 Shanghai Fosun Pharmaceutical Biogeneric Drugs Production Sites and Area Served
- 7.5.2 Biogeneric Drugs Product Introduction, Application and Specification
- 7.5.3 Shanghai Fosun Pharmaceutical Biogeneric Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Tonghua Dongbao Pharmaceutical
- 7.6.1 Tonghua Dongbao Pharmaceutical Biogeneric Drugs Production Sites and Area Served
- 7.6.2 Biogeneric Drugs Product Introduction, Application and Specification
- 7.6.3 Tonghua Dongbao Pharmaceutical Biogeneric Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Biocon
- 7.7.1 Biocon Biogeneric Drugs Production Sites and Area Served
- 7.7.2 Biogeneric Drugs Product Introduction, Application and Specification
- 7.7.3 Biocon Biogeneric Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Reliance life sciences
- 7.8.1 Reliance life sciences Biogeneric Drugs Production Sites and Area Served
- 7.8.2 Biogeneric Drugs Product Introduction, Application and Specification
- 7.8.3 Reliance life sciences Biogeneric Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Probiomed
- 7.9.1 Probiomed Biogeneric Drugs Production Sites and Area Served
- 7.9.2 Biogeneric Drugs Product Introduction, Application and Specification
- 7.9.3 Probiomed Biogeneric Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Biosidus
- 7.10.1 Biosidus Biogeneric Drugs Production Sites and Area Served
- 7.10.2 Biogeneric Drugs Product Introduction, Application and Specification
- 7.10.3 Biosidus Biogeneric Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 AMEGA Biotech
- 7.12 Celltrion
- 7.13 LG life Science
- 7.14 Dong-A Pharmaceutical
8 Biogeneric Drugs Manufacturing Cost Analysis
- 8.1 Biogeneric Drugs Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Biogeneric Drugs
- 8.4 Biogeneric Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Biogeneric Drugs Distributors List
- 9.3 Biogeneric Drugs Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Biogeneric Drugs Market Forecast
- 11.1 Global Biogeneric Drugs Production, Revenue Forecast
- 11.1.1 Global Biogeneric Drugs Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Biogeneric Drugs Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Biogeneric Drugs Price and Trend Forecast (2019-2025)
- 11.2 Global Biogeneric Drugs Production Forecast by Regions (2019-2025)
- 11.2.1 North America Biogeneric Drugs Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Biogeneric Drugs Production, Revenue Forecast (2019-2025)
- 11.2.3 China Biogeneric Drugs Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Biogeneric Drugs Production, Revenue Forecast (2019-2025)
- 11.3 Global Biogeneric Drugs Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Biogeneric Drugs Consumption Forecast (2019-2025)
- 11.3.2 Europe Biogeneric Drugs Consumption Forecast (2019-2025)
- 11.3.3 China Biogeneric Drugs Consumption Forecast (2019-2025)
- 11.3.4 Japan Biogeneric Drugs Consumption Forecast (2019-2025)
- 11.4 Global Biogeneric Drugs Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Biogeneric Drugs Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Biogeneric Drugs . Industry analysis & Market Report on Biogeneric Drugs is a syndicated market report, published as Global Biogeneric Drugs Market Research Report 2019. It is complete Research Study and Industry Analysis of Biogeneric Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
